Compare BIO & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | RRC |
|---|---|---|
| Founded | 1952 | 1976 |
| Country | United States | United States |
| Employees | 7450 | 564 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oil & Gas Production |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 10.9B |
| IPO Year | N/A | 1996 |
| Metric | BIO | RRC |
|---|---|---|
| Price | $278.70 | $45.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | ★ $358.50 | $43.18 |
| AVG Volume (30 Days) | 276.2K | ★ 3.4M |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | N/A | ★ 151.38 |
| EPS | N/A | ★ 2.74 |
| Revenue | N/A | ★ $3,115,515,000.00 |
| Revenue This Year | $2.74 | $13.16 |
| Revenue Next Year | $3.05 | $9.96 |
| P/E Ratio | ★ $9.72 | $16.47 |
| Revenue Growth | N/A | ★ 28.90 |
| 52 Week Low | $211.43 | $30.32 |
| 52 Week High | $343.12 | $48.31 |
| Indicator | BIO | RRC |
|---|---|---|
| Relative Strength Index (RSI) | 54.66 | 60.43 |
| Support Level | $256.85 | $34.07 |
| Resistance Level | $289.61 | N/A |
| Average True Range (ATR) | 8.28 | 1.61 |
| MACD | 1.87 | 0.01 |
| Stochastic Oscillator | 91.98 | 51.01 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.